Controlling dosages of drugs like THC is key to the experience of cannabis consumption, says Canadian company

published on July 31, 2018 by Perrin Grauer in StarMetro Vancouver

With cannabis legalization just around the corner, one Canadian company is calling for the inclusion of cannabis concentrates in Bill C-45, the so-called “Cannabis Act.”

Josh Campbell, president of cannabis company Dosist Canada, says in omitting concentrates from legalization, consumers are being denied a method for consistent delivery of THC and CBD — the two most commonly sought-after drugs contained in the cannabis plant.

View the full article